|
|
Top Story |
 |
Pharm Exec's 2018 Pipeline Report |
Analysis shows that persistence is paying off for drug developers, driven by the rise of CAR-T and other gene therapy, newly discovered cancer targets, better patient identification methods—and the realization that failures have their place in shaping the pipeline of tomorrow. Josh Baxt reports
... /Read more/ |
|
|
Asia |
 |
Taiwan's Biotech Boom |
With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups. Michelle Maskaly reports
... /Read more/ |
|
|
|
Calendar |
/ 14 November: EU GDPR Bootcamp Life Sciences / |
London, UK |
/ November 15-16: 4th Annual Global Compliance Congress for Life Sciences / |
London, UK |
/ November 28–29: Commercial Data Insights / |
Philadelphia, PA |
/ December 4–5: Connected Devices in Healthcare / |
San Diego, CA |
/ December 12: Specialty Products Data Strategy Summit / |
Philadelphia, PA |
/ January 23–24: 13th Biosimilars Summit / |
Alexandria, VA |
/ January 24–25: Reimbursement and Contracting / |
Philadelphia, PA |
/ February 7–8, 2018: Speaker Programs 2018 / |
Philadelphia, PA |
/ March 25–28, 2018: 14th Annual Pharma Forum / |
Philadelphia, PA |
|
|
|
Industry update |
//ALK (Copenhagen, Denmark) announced the appointment of Søren Jelert as its new Chief Financial Officer and Executive Vice President. //The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA; Geneva, Switzerland) named Helen Gallagher as Communications Director. //DelMar Pharmaceuticals (Vancouver, British Columbia and Menlo Park, CA) announced the appointment of Mr. Saiid Zarrabian as interim Chief Executive Officer. //Cambridge Epigenetix (Saffron Walden, UK) appointed Hayden Jeffreys as Chief Operating Officer and Dr. Joanne Mason as Vice President of Biomarker Discovery. //
|
|
|
|